Linsitinib
Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor. This prevents tumor cell proliferation and induces tumor cell apoptosis. Reference standards of Linsitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Linsitinib
[catalogue_number] => PA 65 29000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 421.5
[form] => C26H23N5O
[cas] => 867160-71-2
[pslug] => 867160-71-2-linsitinib-api-pa6529000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
